By NewsDesk  @infectiousdiseasenews

In Costa Rica, the National Vaccination and Epidemiology Commission (CNVE) indicated that immunosuppressed people are included within the population to be vaccinated with a third dose against COVID-19 in 2022, as part of the 2.5 million dose contract currently being negotiated with the Pfizer company.

Public domain image courtesy of Lisa Ferdinando, U.S. Department of Defense

The 2.5 million doses will be distributed as follows:

  • 1.5 million for pediatric population 2 to 12 years (two doses per person, vaccine still in development)
  • 1 million in order to place a third dose at:
    • Immunosuppressed people
    • Over 58 years old
    • First responders.

Taking into account the new scientific evidence, the CNVE will work on the list of pathologies included in the population with immunodeficiencies that will receive the third dose against COVID-19 next year.